The prevalence of irritable bowel symptoms in a population of shopping mall visitors in Santiago de Chile;Prevalencia de sintomas de intestino irritable en poblacioacute;n asistente a centros comerciales de Santiago de Chile

Revista de Gastroenterologia de Mexico

Volumn 78, Issue 4, 2013, Pages 203-210

  Madrid Silva, A M ^a   Defilippi Caffri, C ^b   Landskron Ramos, G ^a   Olguin Herrera, F ^a   Reyes Ponce, A ^a   Castro Lara, A ^a   Larrain Corp, S ^b   Martinez Roje, N ^b   Cortes Espinoza J ^b  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Chile; General population; Irritable bowel syndrome; Prevalence; Santiago

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SURVEY; HUMAN; IRRITABLE COLON; MALE; MIDDLE AGED; POBLACIÓN GENERAL; POPULATION; PREVALENCE; PREVALENCIA; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SANTIAGO; SÍNDROME DE INTESTINO IRRITABLE; SOCIOECONOMICS; VERY ELDERLY; YOUNG ADULT;

CHILE; GENERAL POPULATION; IRRITABLE BOWEL SYNDROME; POBLACIÓN GENERAL; PREVALENCE; PREVALENCIA; SANTIAGO; SÍNDROME DE INTESTINO IRRITABLE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84896517110     PISSN: 03750906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rgmx.2013.07.004     Document Type: Article

References (40)

1. Longstreth G, Thompson W, Chey W, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480-91.
2. Drossman D, Camilleri M, Mayer E, et al. AGA Technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108-31.
3. Camilleri M, Heading R, Thompson W. Consensus report: clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Ther. 2002;16:1407-30.
4. Kanazawa M, Hongo M, Fukudo S. Visceral hypersensitivity in irritable bowel syndrome. J Gastroenterol Hepatol. 2011;26:119-21.
5. Wilder-Smith C, Robert-Yap J. Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome. World J Gastroenterol. 2007;13:3699-704.
6. Bouchoucha M, Devroede G, Dorval E, et al. Different segmental transit times in patients with irritable bowel syndrome and normal colonic transit time: Is there a correlation with symptoms? Tech Coloproctol. 2006;10:287-96.
7. Vassallo M, Camilleri M, Phillips S, et al. Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology. 1992;102:102-8.
8. Lee BJ, Bak YT. Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil. 2011;17:252-66.
9. Tanaka Y, Kanazawa M, Fukudo S, et al. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:131-9.
10. Mitchel C, Drossman D. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology. 1987;92:1282-4.
11. Longstreth G, Wilson A, Knight K, et al. Irritable bowel syndrome, health care use, and costs: A U S. managed care perspective. Am J Gastroenterol. 2003;98:600-7.
12. Drossman D, Li Z, Andruzzi E, et al. U S. Householder survey of functional gastrointestinal disorders. Prevalence, sociodemography and health impact. Dig Dis Sci. 1993;38:1569-80.
13. Hulish D. The burden of illness of irritable bowel syndrome: Current challenges and hope for the future. J Manag Care Pharm. 2004;10:299-309.
14. Katiraei P, Bultron G. Need for a comprehensive medical approach to the neuro-immunogastroenterology of irritable bowel syndrome. World J Gastroenterol. 2011;17:2791-800.
15. Valenzuela J, Alvarado J, Cohen H, et al. Un consenso latinoamericano sobre el sindrome del intestino irritable. Gastroenterol Hepatol. 2004;27:325-43.
16. Drossman D, Corazziari E, Talley N, et al., editores. Research diagnostic questions for functional gastrointestinal disorders. The functional gastroeintestinal disorders. Second edition Virginia: Degon Associates Mc Lean; 2000. p. 669-714.
17. Zuckerman M, Guerra L, Drossman D, et al. Comparison of bowel patterns in Hispanics and non-hispanic whites. Dig Dis Sci. 1995;40:1763-9.
18. Hungin AP, Whorwell PJ, Tack J, et al. The prevalence, patterns and impact of irritable bowel syndrome: An international survey of 40 000 subjects. Aliment Pharmacol Ther. 2003;17:643-50.
19. Hungin A, Chang L, Locke G, et al. Irritable bowel syndrome in the United States: Prevalence, symptom patterns and impact. Aliment Pharmacol Ther. 2005;21:1365-75.
20. López Colombo A, Morgan D, Bravo González D, et al. The epidemiology of functional gastrointestinal disorders in Mexico: A population based study. Gastroenterol Res Pract. 2012;2012:606174.
21. Valerio-Ureña J, Vásquez-Fernández F, Jiménez-Pineda A, et al. Prevalence of irritable bowel syndrome in Veracruz City, Mexico: A community-based survey. Rev Gastroenterol Mex. 2010;75:36-41.
22. Gómez-Alvarez DF, Morales Vargas JG, Rojas Medina LM, et al. Prevalence of irritable bowel syndrome and associated factors according to the Rome III diagnostic criteria in a general population in Colombia. Gastroenterol Hepatol. 2009;32:395-400.
23. Iade B, Toma R. Frecuencia del sindrome de intestino irritable en una población de Montevideo. Arch Med Int. 2003;4:91-6.
24. Flores S, Berdichevsky E, Castro M, et al. El sindrome de intestino irritable. La percepción médica. Encuesta de opinión. Gastroenterol Latinoam. 2000;11:357.
25. Olubuyide I, Olawuyi F, Fasanmade A. A study of irritable bowel syndrome diagnosed by Manning criteria in an African population. Dig Dis Sci. 1995;40:983-5.
26. Olguin F, Madrid A, Catalá M, et al. Prevalencia del sindrome de intestino irritable en población mapuche. Gastroenterol latinoam. 2009;20:238.
27. Rey E, Talley N. Irritable bowel syndrome: Novel views on the epidemiology and potential risk factors. Dig Liver Dis. 2009;41:772-80.
28. Wilson S, Roberts L, Roalfe A, et al. Prevalence of irritable bowel syndrome: A community survey. Br J Gen Pract. 2004;54:495-502.
29. Grundmann O, Yoon S. Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for health-care practitioners. J Gastroenterol Hepatol. 2010;25:691-9.
30. Chang L, Toner B, Fukudo S, et al. Gender, age, society, culture and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology. 2006;130:1435-44.
31. Jerndal P, Ringström G, Agerforz P, et al. Gastrointestinalspecific anxiety: An important factor for severity of GI symptoms and quality of life in IBS. Neurogastroenterol Motil. 2010;22:646-79.
32. Saito Y, Zimmerman J, Harmsen W, et al. Irritable bowel syndrome aggregates strongly in families: A family-based casecontrol study. Neurogastroenterol Motil. 2008;20:790-7.
33. Kanazawa M, Endo Y, Whitehead W, et al. Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig Dis Sci. 2004;49:1046-53.
34. Levy R, Whitehead W, Von Korff M, et al. Intergenerational transmission of gastrointestinal illness behavior. Am J Gastroenterol. 2000;95:451-6.
35. Morris-Yates A, Talley N, Boyce P, et al. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol. 1998;93:1311-7.
36. Mohammed I, Cherkas L, Riley S, et al. Genetic influences in irritable bowel syndrome: A twin study. Am J Gastroenterol. 2005;100:1340-4.
37. Saito YA, Mitra N, Mayer E. Genetic approaches to functional gastrointestinal disorders. Gastroenterology. 2010;138: 1276-85.
38. Hotoleanu C, Popp R, Pavel Trifa A, et al. Genetic determination of irritable bowel syndrome. World J Gastroenterol. 2008;14:6636-40.
39. Longstreth G, Yao J. Irritable bowel syndrome and surgery: A multivariable analysis. Gastroenterology. 2004;126: 1665-73.
40. Schmulson MJ. El escrutinio diagnóstico limitado puede disminuir el impacto económico directo del sindrome de intestino irritable (SII). Rev Med Chile. 2008;136:1398-405.